Alignment Healthcare (NASDAQ:ALHC) Price Target Increased to $9.00 by Analysts at UBS Group

Alignment Healthcare (NASDAQ:ALHC – Free Report) had its price objective increased by UBS Group from $6.50 to $9.00 in a report released on Thursday, Benzinga reports. They currently have a neutral rating on the stock. A number of other research analysts have also recently issued reports on the company. Morgan Stanley decreased their target price […]

Leave a Reply

Your email address will not be published.

Previous post GXO Logistics (NYSE:GXO) Price Target Cut to $67.00
Next post Liquidia (NASDAQ:LQDA) Given Underperform Rating at Wedbush